Lars Bjornebo, MSC

Karolinska Institute

Lars Björnebo, MSc. MD/PhD Candidate at Karolinska Institute, Sweden.

Research focusing on improving diagnostics and active surveillance protocols for prostate cancer. Clinical experience working in the uro-oncology department at the South General Hospital in Stockholm. Graduating from medical school this spring and am aiming for a residency in urology or oncology.

Disclosure information not submitted.

Presentation(s):

• PD03-02: Long-Term Effects of 5&[alpha]-Reductase Inhibitors on Prostate Cancer Mortality - a Large Population-Based Prospective Study

  Friday, May 13, 2022
  7:10 AM – 7:20 AM

• MP58-03: Prostate Cancer Screening - a Novel Risk Prediction Tool with Standard Biopsies vs. PSA with MRI-Targeted Biopsies

  Monday, May 16, 2022
  1:00 PM – 2:15 PM